Microneedle-mediated transdermal bacteriophage delivery

European Journal of Pharmaceutical Sciences

Volumn 47, Issue 2, 2012, Pages 297-304

  Ryan, Elizabeth ^a   Garland, Martin J ^a   Singh, Thakur Raghu Raj ^a   Bambury, Eoin ^b   O'Dea, John ^b   Migalska, Katarzyna ^a   Gorman, Sean P ^a   McCarthy, Helen O ^a   Gilmore, Brendan F ^a   Donnelly, Ryan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Galway Business Park   (Ireland)

Author keywords

Bacterial infection; Bacteriophage therapy; Hollow microneedle; Transdermal delivery

Indexed keywords

POLYCARBONATE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; BACTERIOPHAGE T4; DERMATOME; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; IN VITRO STUDY; IN VIVO STUDY; MALE; MICRONEEDLE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION; VIRAL CLEARANCE; VIRUS PLAQUE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANIMALS, NEWBORN; BACTERIOPHAGE T4; ESCHERICHIA COLI; MALE; MICROINJECTIONS; NEEDLES; POLYCARBOXYLATE CEMENT; RATS; RATS, SPRAGUE-DAWLEY; SWINE;

EID: 84864062865     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.06.012     Document Type: Article

References (41)

1. M.H. Adams Bacteriophages 1959 Interscience New York
2. M.A. Arap Phage display technology: applications and innovations Genet. Mol. Biol. 28 2005 1 9
3. W. Arap, R. Pasqualini, and E. Ruoslahti Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 1998 377 380
4. P. Barrow, M. Lovell, and A. Berchieri Use of lytic bacteriophage for control of experimental E. coli septicemia and meningitis in chickens and calves Clin. Diagn. Lab. Immunol. 5 1998 294 298
5. B.W. Barry Novel mechanisms and devices to enable successful transdermal drug delivery Eur. J. Pharm. Sci. 14 2001 101 114
6. B. Biswas, S. Adhya, P. Washart, B. Paul, A.N. Trostel, B. Powell, R. Carlton, and C.R. Merril Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant enterococcus faecium Infect. Immunol. 70 2002 204 210
7. L. Broxmeyer, D. Sosnowska, E. Miltner, O. Chacon, D. Wagner, J. McGarvey, R.G. Barletta, and L. Bermudez Killing of mycobacterium avium and mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens J. Infect. Dis. 186 2002 1155 1160
8. A. Bruttin, and H. Brüssow Human volunteers receiving E. coli phage T4 orally: a safety test of phage therapy Antimicrob. Agents Ch. 49 2004 2874 2878
9. R. Capparelli, M. Parlato, G. Borriello, P. Salvatore, and D. Iannelli Experimental phage therapy against staphylococcus aureus in mice Antimicrob. Agents Ch. 51 2007 2765 2773
10. K.E. Cerveny, A. DePaola, D.H. Duckworth, and P.A. Gulig Phage therapy of local and systemic disease caused by vibrio vulnificus in iron-dextran-treated Mice Infect. Immunol. 70 2002 6251 6262
11. S. Chibani-Chennoufi, A. Bruttin, M.L. Dillman, and H. Brüssow Phage-host interaction: an ecological perspective J. Bacteriol. 186 2004 3677 3686
12. A.J. Darling, J.A. Boose, and J. Spaltro Virus assay methods: accuracy and validation J. Internat. Assoc. Biol. Standard. 26 1998 105 110
13. R.F. Donnelly, D.I. Morrow, F. Fay, C.J. Scott, S. Abdelghany, R.T. Singh, M.J. Garland, and A.D. Woolfson Microneedle-mediated intradermal nanoparticle delivery: potential for enhanced local administration of hydrophobic pre-formed photosensitisers Photodiag. Photodyn. Ther. 7 2010 222 231
14. R.F. Donnelly, T.R. Singh, and A.D. Woolfson Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety Drug Deliv. 17 2010 187 207
15. R.F. Donnelly, M.J. Garland, D.I. Morrow, K. Migalska, T.R. Singh, R. Majithiya, and A.D. Woolfson Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution J. Cont. Rel. 147 2010 333 341
16. R.F. Donnelly, R. Majithiya, T.R. Singh, D.I. Morrow, M.J. Garland, Y.K. Demir, K. Migalska, E. Ryan, D. Gillen, C.J. Scott, and A.D. Woolfson Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique Pharm. Res. 28 2011 41 57
17. H.J.G.E. Gardeniers, R. Luttge, E.J.W. Berenschot, M.J. de Boer, S.Y. Yeshurun, M. Hefetz, R. van't Oever, and A. van den Berg Silicon micromachined hollow microneedles for transdermal liquid transport J. Microelectrom. Syst. 12 2003 855 862
18. M.J. Garland, K. Migalska, T.M. Mahmood, T.R. Singh, A.D. Woolfson, and R.F. Donnelly Microneedle arrays as medical devices for enhanced transdermal drug delivery Expert Rev. Med. Dev. 8 2011 459 482
19. R.W. Hendrix Bacteriophages: evolution of the majority Theor. Popul. Biol. 61 2002 471 480
20. W.E. Huff, G.R. Huff, N.C. Rath, J.M. Balog, and A.M. Donoghue Evaluation of aerosol spray and intramuscular injection of bacteriophage to treat an E. coli respiratory infection Poultry Sci. 82 2003 1108 1112
21. C.J. Inchley The activity of mouse Kupffer cells following intravenous injection of T4 bacteriophage Clin. Expert Immunol. 5 1969 173 187
22. D. Larocca, P.D. Kassner, A. Witte, R.C. Ladner, G.F. Pierce, and A. Baird Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage FASEB. J. 13 1999 727 734
23. C. Mao, A. Liu, and B. Cao Virus-based chemical and biological sensing Angew. Chem. Int. Ed. 48 2009 6790 6810
24. W. Martanto, J.S. Moore, O. Kashlan, R. Kamath, P.M. Wang, J.M. O'Neal, and M.R. Prausnitz Microinfusion using hollow microneedles Pharm. Res. 23 2006 104 113
25. S. Matsuzaki, M. Yasuda, H. Nishikawa, M. Kuroda, T. Ujihara, T. Shuin, Y. Shen, Z. Jin, S. Fujimoto, M.D. Nasimuzzaman, H. Wakiguchi, S. Sugihara, T. Sugiura, S. Koda, A. Muraoka, and S. Imai Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage fMR11 J. Infect. Dis. 187 2003 613 624
26. C.S. McVay, M. Velásquez, and J.A. Fralick Phage therapy of pseudomonas aeruginosa infection in a mouse burn wound model Antimicrob. Agents Ch. 51 2007 1934 1938
27. K. Migalska, D.I. Morrow, M.J. Garland, R.T. Singh, A.D. Woolfson, and R.F. Donnelly Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery pharm Res. 28 2011 1919 1930
28. P. Mikolajewska, R.F. Donnelly, M.J. Garland, D.I. Morrow, T.R. Singh, V. Iani, J. Moan, and A. Juzeniene Microneedle pre-treatment of human skin improves 5-Aminolevulininc Acid (ALA)- and 5-Aminolevulinic Acid Methyl Ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema Pharm. Res. 27 2010 2213 2220
29. A.D. Morris, D.I. Boyle, A.D. McMahon, S.A. Greene, T.M. MacDonald, and R.W. Newton Adherence to insulin treatment, glycaemic control and ketoacidosis in insulin-dependent diabetes mellitus Lancet 350 1997 1505 1510
30. H. Okyama, and P. Berg Bacteriophage lambda vector for transducing a cDNA clone library into mammalian cells Mol. Cell. Biol. 5 1985 1136 1142
31. R.J. Payne, and V.A. Jansen Pharmacokinetic principles of bacteriophage therapy Clin. Pharmacokin. 42 2003 315 325
32. D. Payne, and A. Tomasz The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents Curr. Opin. Microbiol. 7 2004 435 438
33. R.J. Payne, D. Phil, and V.A. Jansen Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals Clin. Pharmacol. Therap. 68 2000 225 230
34. M.R. Prausnitz Microneedles for transdermal drug delivery Adv. Drug. Del. Rev. 56 2004 581 587
35. C. Rhyner, M. Weichel, S. Flukiger, S. Hemmann, T. Kleber-Janke, and R. Crameri Cloning allergens via phage display Methods 32 2004 212 218
36. E.M. Ryan, S.P. Gorman, R.F. Donnelly, and B.F. Gilmore Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy J. Pharm. Pharmacol. 63 2011 1253 1264
37. A. Sulakvelidze, Z. Alavidze, and J.G. Morris Bacteriophage therapy Antimicrob. Agents Ch. 45 2001 649 659
38. T. Tanner, and R. Marks Delivering drugs by the transdermal route: review and comment Skin Res. Technol. 14 2008 249 260
39. A.C. Williams Theoretical Aspects of Transdermal Drug Delivery, Transdermal and Topical Drug Delivery 2003 Pharmaceutical Press
40. Q.F. Wills, C. Kerrigan, and J.S. Soothill Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model Antimicrob. Agents Ch. 49 2005 1220 1221
41. M. Yokohama-Kobayashi, and S. Kato Recombinant f1 phage particles can transfect monkey COS-7 cells by DEAE dextran method Biochem. Biophys. Res. Comm. 192 1993 935 939